Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

NCT07308769 is registered in ClinicalTrials.gov with Pharmanutra S.p.a. as lead sponsor.

NCT NCT07308769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Lead sponsor
Pharmanutra S.p.a.
Phase
Phase 4
Overall status
Recruiting
Start date
December 11, 2025
Completion date
October 31, 2026
Enrollment
146 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron deficiency anemia (ida)